Omega Therapeutics

📍 Cambridge, United States🗓 Founded 2017👥 29 employees💰 Last funded Oct 2024
Biotechnology Research🌐 omegatherapeutics.com
Website LinkedIn
Omega Therapeutics is a clinical-stage biotechnology company pioneering the first systematic approach of using mRNA as programmable epigenomic medicines. Our OMEGA platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organisms life from cell genesis, growth and differentiation to cell death. The OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by returning aberrant gene expression to a normal range without altering native nucleic acid sequences. Omega’s engineered, modular, and programmable mRNA medicines, Omega Epigenomic Controllers™, target specific intervention points amongst the thousands of mapped and validated novel DNA-sequence-based epigenomic loci to durably tune single or multiple genes to treat and cure disease through unprecedented precision epigenomic control. Omega has a broad pipeline of development candidates spanning a range of disease areas, including oncology, regenerative medicine, multigenic diseases including immunology, and select monogenic diseases.
4
Total investors
3
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2016–2024 · investors recorded per year
20161201712019120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Omega Therapeutics?
Omega Therapeutics has 4 investors on record on gritt.io, including 3 early-stage backers and 1 late-stage investors.
When did Omega Therapeutics last raise funding?
The most recent investment in Omega Therapeutics recorded on gritt.io was in October 2024.
When was Omega Therapeutics founded?
Omega Therapeutics was founded in 2017.
What industry is Omega Therapeutics in?
Omega Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Omega Therapeutics based?
Omega Therapeutics is headquartered in Cambridge, United States.